Balanced news tone
News Sentiment
CBLL sentiment intelligence
CeriBell, Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
+0.1% over one week, +5.9% over four weeks, trend inactive, and near fair-value range.
Return on assets % of Ceribell, Inc. – FWB:W3H
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
Return on assets % of Ceribell, Inc. – FWB:W3H
This article provides financial information for Ceribell, Inc. (FWB:W3H) on TradingView, specifically focusing on its Return on Assets percentage. It indicates that the market for W3H on the Frankfurt Stock Exchange is currently closed with no trades. The content is part of a lar
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 14:41
- Source
- TradingView
Cost of goods sold of Ceribell, Inc. – DUS:W3H
This article provides financial information for Ceribell, Inc. (DUS:W3H) on TradingView, specifically focusing on its cost of goods sold. It details that the market is currently closed with no trades recorded. The content is sourced from ICE Data Services, FactSet, and Quartr for
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 14:41
- Source
- TradingView
EBITDA of Ceribell, Inc. – DUS:W3H
The article displays the EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) for Ceribell, Inc., traded on the Dusseldorf Stock Exchange under the ticker W3H. It shows the period, value, change, and percentage change. This financial data is provided by Tradin
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Jul 2026 14:40
- Source
- TradingView
W3H Stock Price and Chart — FWB:W3H
This article provides details on Ceribell, Inc. (W3H) stock traded on the Frankfurt Stock Exchange, including key financial metrics, upcoming earnings, and analyst ratings. It highlights the company's focus on medical technology for neurological conditions, its products like Poin
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 03 Jul 2026 20:40
- Source
- TradingView
Ceribell director William Burke sells $43,786 in company stock. By Investing.com
William W. Burke, a director at Ceribell, Inc. (NASDAQ: CBLL), sold 2,207 shares of company stock for $43,786 on June 30, 2026, through a Rule 10b5-1 trading plan. Despite a recent 1.4% stock gain, InvestingPro suggests the stock is overvalued. Ceribell, a medical technology comp
- Tone
- Negative 37/100
- Event
- Market update
- Published
- 03 Jul 2026 12:12
- Source
- Investing.com Nigeria
Price to book forward of CeriBell, Inc. – NASDAQ:CBLL
This page from TradingView provides financial information for CeriBell, Inc. (NASDAQ:CBLL), specifically focusing on its "Price to book forward" metric. The article is a stub, indicating that the detailed financial data for this specific metric was not fully loaded or is presente
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 11:39
- Source
- TradingView
Cost of goods sold of Ceribell, Inc. – TRADEGATE:W3H
This article provides access to the cost of goods sold for Ceribell, Inc. (W3H) on the Tradegate Exchange. It highlights the financial data available through TradingView, noting that the market is currently closed with no trades. The content also lists various data providers and
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 11:39
- Source
- TradingView
Preferred dividends of Ceribell, Inc. – FWB:W3H
This article concerns the preferred dividends of Ceribell, Inc., traded on the Frankfurt Stock Exchange under the ticker W3H. The content is presented within the TradingView platform, which provides financial data and tools for market analysis. The article displays a section for
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 00:13
- Source
- TradingView
Enterprise value to revenue forward of CeriBell, Inc. – NASDAQ:CBLL
This article provides financial information for CeriBell, Inc. (NASDAQ: CBLL) focusing on its enterprise value to revenue forward. It appears to be a stub or a report snippet from TradingView, indicating no current trades and directing users to more detailed financial data, news,
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Jul 2026 23:40
- Source
- TradingView
Net income before discontinued operations of Ceribell, Inc. – FWB:W3H
The article focuses on the "Net income before discontinued operations" for Ceribell, Inc. (FWB:W3H) on the Frankfurt Stock Exchange, as tracked by TradingView. It appears to be a financial data page rather than a news article, displaying a specific financial metric for the compan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 23:09
- Source
- TradingView
Price to book forward of Ceribell, Inc. – FWB:W3H
This article focuses on the "Price to book forward" financial metric for Ceribell, Inc. (FWB:W3H) on the Frankfurt Stock Exchange, as presented on TradingView. The page displays the company's identifier, market status, and offers various financial and community-related data. It i
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 21:40
- Source
- TradingView
Ceribell, Inc. Cash Flow – FWB:W3H
This article provides key cash flow information for Ceribell, Inc. (FWB:W3H). It highlights that the company's free cash flow for Q1 2026 was -16.81M EUR, and for 2025, it was -35.53M EUR, with operating cash flow at -34.87M EUR. The article includes sections for cash flow from o
- Tone
- Negative 30/100
- Event
- Balance sheet
- Published
- 02 Jul 2026 21:40
- Source
- TradingView
Ceribell(CBLL.US) Insider Sells US$4.07 Million in Common Stock
A significant insider stock sale at Ceribell (CBLL.US) has been reported, with an insider divesting common stock valued at $4.07 million. This transaction could be of interest to investors monitoring insider activity as an indicator of company performance or future outlook.
- Tone
- Negative 28/100
- Event
- Guidance
- Published
- 01 Jul 2026 00:09
- Source
- Moomoo
Is CeriBell, Inc. (CBLL) Among the Best Brain-Computer Interface Stocks to Buy?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 27 Jun 2026 07:00
- Source
- Market source
Ceribell, Inc. (CBLL) reports Q1 loss, beats revenue estimates
Ceribell, Inc. (CBLL) reported its first-quarter financial results, showing a loss per share but exceeding revenue expectations. This indicates that while the company is still operating at a loss, its sales performance was stronger than analysts had predicted for the quarter.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jun 2026 02:39
- Source
- MSN
Ceribell, Inc. Actuals & Estimates (NASDAQ:CBLL)
This article provides an overview of Ceribell, Inc. (NASDAQ:CBLL) stock performance, financial actuals, and analyst estimates. It highlights recent price movements, market capitalization, upcoming earnings reports, and analyst forecasts for its future stock price. The article als
- Tone
- Positive 67/100
- Event
- Earnings
- Published
- 26 Jun 2026 11:41
- Source
- TradingView
CBLL Forecast — Price Target — Prediction for 2027
This article provides a detailed forecast for CeriBell, Inc. (CBLL) stock, including analyst price targets, historical performance, and key financial metrics. It highlights that analysts have a max estimated future price of $32.00 and a min estimate of $24.00, while the stock has
- Tone
- Positive 65/100
- Event
- Analyst action
- Published
- 25 Jun 2026 21:39
- Source
- TradingView
CeriBell Inc (CBLL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
CeriBell Inc (CBLL) generated a total revenue of $89.06 million, with 75.60% ($67.33 million) coming from EEG recorders and headbands, and 24.40% ($21.73 million) from EEG portal and Clarity subscriptions. All reported revenue for the company came from the United States. This dat
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jun 2026 10:40
- Source
- TradingKey
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jun 2026 07:00
- Source
- StockStory
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- Market source
Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- Market source
A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Mar 2026 07:00
- Source
- Market source
Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Mar 2026 07:00
- Source
- StockStory
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- Market source
Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Mar 2026 07:00
- Source
- Market source
Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Mar 2026 08:00
- Source
- Market source
CeriBell, Inc. Common Stock (CBLL) Stock Price Today & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jan 2026 01:03
- Source
- Gotrade